Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,426-2,450 of 3,186
CompletedNCT05660070

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT06225115

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years

This study exists to compare options and see whether the medication KYN-5356 offers something meaningfully different. Researchers are trying to understand how people respond to the medication KYN-5356 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Kynexis B.V.
Condition
Schizophrenia
CompletedNCT03583073

Psychosis Screening in Juvenile Justice

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Brown University
Condition
Schizophrenia
RecruitingNCT05457140

Multiomic Diagnostics in Youth With Psychosis

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 7 Years to 17 Years
Countries
United States
Sponsor
Rady Pediatric Genomics & Systems Medicine Institute
Condition
Schizophrenia
CompletedNCT03557931

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia
CompletedNCT05105542

M1 Schizophrenia PET Study

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT03621774

Mobile CBT for Negative Symptoms

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Bulgaria, Poland, Serbia, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
CompletedNCT02720263

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia
CompletedNCT03356639

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia
CompletedNCT04659174

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Ukraine, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
CompletedNCT06653829

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Shore Therapeutics, Inc.
Condition
Schizophrenia
CompletedNCT03669250

CVN058 Effect on Mismatch Negativity in Schizophrenics

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Cerevance Alpha, Inc.
Condition
Schizophrenia
CompletedNCT04001114

Cigarette Smoking in Smokers With and Without Schizophrenia

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT04046497

Artificial Intelligence to Measure Adherence to Oral Medication

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT04004364

Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT01853020

Cannabinoids and Cerebellar-Motor Functioning

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 21 Years to 35 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT03995368

Neuroplasticity in TBI and Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 25 Years to 55 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT01911676

Translational Neuroscience Optimization of GlyT1 Inhibitor

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 21 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia